NPI: 1912982216 · ORANGE, CA 92868 · General Acute Care Hospital · NPI assigned 12/08/2005
Authorized official ANDERSON, DONALD controls 20+ related entities in our dataset. Read more
| Authorized Official | ANDERSON, DONALD (ASSISTANT SECRETARY ENROLLMENTS) |
| NPI Enumeration Date | 12/08/2005 |
Other providers sharing the same authorized official: ANDERSON, DONALD
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 143 | $0.00 |
| 2021 | 1,780 | $198.91 |
| 2022 | 288 | $3K |
| 2023 | 4,485 | $2K |
| 2024 | 920 | $288.14 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 358 | 337 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | 257 | 220 | $858.64 |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 387 | 378 | $820.40 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 867 | 770 | $463.34 |
| 80053 | Comprehensive metabolic panel | 580 | 543 | $458.75 |
| 71045 | Radiologic examination, chest; single view | 233 | 225 | $225.26 |
| 0450 | Emergency room services | 429 | 380 | $133.28 |
| 80048 | Basic metabolic panel (calcium, ionized) | 214 | 172 | $107.36 |
| 83690 | 325 | 307 | $81.27 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 104 | 96 | $70.60 |
| 84702 | 134 | 124 | $59.75 | |
| 84484 | 137 | 118 | $43.83 | |
| 81003 | 238 | 232 | $40.80 | |
| 82947 | 104 | 80 | $31.19 | |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 1,214 | 1,122 | $23.77 |
| 81001 | 223 | 209 | $21.01 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 68 | 57 | $14.67 |
| 81025 | 39 | 38 | $14.60 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 38 | 38 | $14.36 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 126 | 119 | $11.25 |
| J3490 | Unclassified drugs | 751 | 398 | $10.34 |
| 80076 | 104 | 92 | $6.78 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 144 | 128 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 49 | 45 | $0.00 |
| 0272 | 20 | 12 | $0.00 | |
| 0160 | 12 | 12 | $0.00 | |
| 0270 | 347 | 176 | $0.00 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 30 | 29 | $0.00 |
| 96361 | Intravenous infusion, hydration; each additional hour | 13 | 12 | $0.00 |
| 96376 | 71 | 47 | $0.00 |